Online Health Wealth Care

Respiratory syncytial virus (RSV) is a common virus that can lead to bronchitis and pneumonia in babies and young children. Fortunately, we now have RSV vaccines that can help protect infants against this potentially dangerous virus. Here's what parents need to know about the RSV vaccine schedule for babies: When can babies get the RSV vaccine? RSV Vaccine for Babies : There are currently two RSV vaccines approved for use in infants - Palivizumab (Synagis) and Nirsevimab (Beyfortus). Palivizumab is approved for preterm infants born before 29 weeks gestation, as well as infants with certain heart or lung conditions that make them high-risk. The first dose is given within the first 28 days of life, with subsequent monthly doses given during RSV season. Nirsevimab was recently approved by the FDA for use in all infants entering their first RSV season. The vaccine is given in a series of two injections - the first between 2-5 months old, with the second dose in the subsequent RSV seaso

Respiratory syncytial virus (RSV) causes lung infections resulting in over 3 million hospital visits annually. For babies, RSV can be especially dangerous. A new RSV vaccine offers hope to protect our youngest and most vulnerable. Let go to discuss about New RSV Vaccine for Babies . How RSV Impacts Infants? RSV leads to severe bronchiolitis and pneumonia in babies. Infants have tiny, underdeveloped airways that become inflamed and filled with mucus from RSV. They struggle breathing, leading to hospitalization in 2-3% of RSV cases under age 1. Long-Term Effects Studies show early severe RSV infections are linked with developing asthma and wheezing disorders later in childhood. An effective RSV vaccine can potentially reduce lasting respiratory effects. Exciting Advances in RSV Vaccines Several pharmaceutical companies are testing RSV vaccine candidates, but none are currently approved for the under 6 months old group. Maternal Vaccination One promising approach is maternal RSV